Organisation paid for research Program year 2023 Source: CMS Open Payments

Biotech Pharmaceuticals Group LLC

Neither a doctor nor a teaching hospital

Research payments

$12,581

5 payments

Through program year 2023, Biotech Pharmaceuticals Group LLC is reported as receiving $12,581 in research payments, across 5 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$807	1
2022	Research	$9,705	2
2021	Research	$2,069	2

Breakdown

Who paid Research payments · program years 2021–2023

AbbVie, Inc. $10,512 3 payments
Allergan Inc. $2,069 2 payments

Studies the money was for Research payments · program years 2021–2023

Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C $10,512 3 payments
Chronic Idiopathic Constipation (Cic),Irritable Bowel Syndrome With Constipation (Ibs-C) $1,265 1 payment
A Phase 2, Randomized, Double-Blind Placebo-Controlled Parallel-Group, Dose Ranging Study to Evaluate the Safety and Efficacy of Eluxadoline in Pediatric Patients (Aged 12-17) With Irritable Bowel Syndrome With Diarrhea (Ibs-D) $804 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.